Tienan Yi
Education University of Hong Kong(HK)Guangdong Provincial Hospital of Traditional Chinese Medicine(CN)Xiangyang Central Hospital(CN)Beihang University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study(2022)298 cited
- → Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study(2021)65 cited
- → Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer(2011)52 cited
- → Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study(2023)30 cited
- → Prognostic value of TP/PD-ECGF and thrombocytosis in gastric carcinoma(2012)26 cited